SCHEMBL6173378

SCHEMBL6173378

CCCCNCC(O)CO

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
ALDH1A1 P00352 3/20 0.40
USP2 O75604 1/20 0.39
ANPEP P15144 1/20 0.39
ERAP2 Q6P179 1/20 0.39
KDM4E B2RXH2 2/20 0.35
PKM P14618 1/20 0.35
LMNA P02545 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
DUSP3 P51452 1/20 0.35
ADH1B P00325 1/20 0.34
ADH1C P00326 1/20 0.34
ADH1A P07327 1/20 0.34
ADH7 P40394 1/20 0.34
ABCB1 P08183 2/20 0.33
DRD3 P35462 1/20 0.33
SLC6A3 Q01959 1/20 0.33
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7705657 0.93 ALDH1A1 (0.50) TSHRALDH1A1USP2ANPEPERAP2
SCHEMBL3837850 0.91 ANPEP (0.49) TSHRALDH1A1USP2ANPEPERAP2
SCHEMBL28399146 0.91 ANPEP (0.49) TSHRALDH1A1USP2ANPEPERAP2
SCHEMBL28392997 0.91 ANPEP (0.49) TSHRALDH1A1USP2ANPEPERAP2
SCHEMBL24835071 0.91 ANPEP (0.49) TSHRALDH1A1USP2ANPEPERAP2
SCHEMBL24835020 0.91 ANPEP (0.49) TSHRALDH1A1USP2ANPEPERAP2
SCHEMBL6924948 0.91 ANPEP (0.49) TSHRALDH1A1USP2ANPEPERAP2
SCHEMBL9115910 0.91 ANPEP (0.49) TSHRALDH1A1USP2ANPEPERAP2
SCHEMBL3842331 0.91 ANPEP (0.49) TSHRALDH1A1USP2ANPEPERAP2
SCHEMBL745702 0.91 ANPEP (0.49) TSHRALDH1A1USP2ANPEPERAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118772009-A Novel amide-ester ashless friction improver and preparation method thereof 中国科学院上海有机化学研究所 2024-10-15 CN claimed
US-20030114473-A1 Pyrimidine compounds ASTRAZENECA AB (SE) 2003-06-19 US claimed
EP-4613403-A1 SOLVENT COMPOSITION AND METHOD FOR PRODUCING SINTERED OBJECT Daicel Corporation (JP) 2025-09-10 EP disclosed
CN-120129581-A Solvent composition and method for producing sintered body 株式会社大赛璐 2025-06-10 CN disclosed
US-12318838-B2 Dispersion medium for metal particle sintering, and electroconductive paste DAICEL CORPORATION (JP) 2025-06-03 US disclosed
WO-2025053146-A1 ALLOY, PARTICLES, ALLOY RIBBON, PREFORM, SINTERED BODY, JOINED BODY, ELECTRONIC DEVICE, AND SINTERED BODY PRODUCTION METHOD 株式会社ダイセル 2025-03-13 WO disclosed
CN-115151360-B Dispersion medium for sintering metal particles and conductive paste 株式会社大赛璐 2025-01-07 CN disclosed
WO-2024248066-A1 POLYMER, PHOTOSENSITIVE RESIN COMPOSITION CONTAINING SAME, COPPER PASTE, LIQUID COMPOSITION, METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE, AND METHOD FOR MANUFACTURING COPPER PILLAR FOR SEMICONDUCTOR CONNECTION 株式会社ダイセル 2024-12-05 WO disclosed
WO-2024248065-A1 POLYMER AND PHOTOSENSITIVE RESIN COMPOSITION CONTAINING SAME, COPPER PASTE, LIQUID COMPOSITION, METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE, AND METHOD FOR MANUFACTURING COPPER PILLAR FOR SEMICONDUCTOR CONNECTION 株式会社ダイセル 2024-12-05 WO disclosed
WO-2024248064-A1 POLYMER, PHOTOSENSITIVE RESIN COMPOSITION CONTAINING SAME, COPPER PASTE, LIQUID COMPOSITION, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND METHOD FOR PRODUCING COPPER PILLAR FOR SEMICONDUCTOR CONNECTION 株式会社ダイセル 2024-12-05 WO disclosed
WO-2024247624-A1 METAL PASTE AND METAL PARTICLE AGGREGATE 株式会社ダイセル 2024-12-05 WO disclosed
WO-2012155042-A2 NOVEL BORATE DERIVATIVES AND THEIR APPLICATIONS ANDERSON DEVELOPMENT COMPANY (US) 2012-11-15 WO disclosed
EP-1246814-B1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARM INC (US) 2005-02-16 EP disclosed
US-6344576-B1 CATIONIC PHOSPHATIDES AND GLYCERIDES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2002-02-05 US disclosed
US-4853383-A β-blocking substituted imidazoles MERCK & CO., INC. (US) 1989-08-01 US disclosed
US-4440774-A ANTIHYPERTENSIVE AGENTS AND B-ANDRENERGIC BLOCKING AGENTS MERCK & CO., INC. (US) 1984-04-03 US disclosed
US-4199580-A HYPOTENSIVE AGENTS AND ADRENERGIC BLOCKING AGENTS MERCK & CO., INC. (US) 1980-04-22 US disclosed
US-4134983-A HYPOTENSIVE, ADRENERGIC BLOCKING AGENTS MERCK & CO., INC. (US) 1979-01-16 US disclosed
US-4019891-A Process for controlling algae with tetrahydro-1,3-thiazinium salts PENNWALT CORPORATION (US) 1977-04-26 US disclosed
US-3966929-A Process for controlling bacteria with tetrahydro-1,3-thiazinium salts PENNWALT CORPORATION (US) 1976-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030114473-A1 Pyrimidine compounds CDK2, CDK1, CCNY TSHR 3708/4885ALDH1A1 1586/4885USP2 3703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.